Comments
GSK says new data support filing of diabetes drug
04.04.2012. | LONDON (Reuters) - GlaxoSmithKline will push ahead with plans to file its experimental once-weekly diabetes drug albiglutide for regulatory approval, following the read-out from a series of clinical trials....
